CHAPLIN DAVID 4
4 · OXIGENE INC · Filed Apr 29, 2010
Insider Transaction Report
Form 4
OXIGENE INCOXGN
CHAPLIN DAVID
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2010-04-27+400,000→ 400,000 totalExercise: $1.06From: 2010-10-27Exp: 2020-04-27→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]The Stock Options will vest in eight equal semi-annual installments over four years beginning six months from the grant date.